Uptick in S. Africa Covid cases as fourth wave looms

 Covid-19 vaccine

A man receives Covid-19 vaccine in South Africa. Covid infections are on the rise in South Africa weeks ahead of an expected fourth wave in December 2021. FILE PHOTO | AFP

What you need to know:

  • The National Institute for Communicable Diseases (NICD) reported a "sustained" increase over the past seven days, with the majority of cases detected in the most populous province of Gauteng, which includes Johannesburg and Pretoria.
  • South Africa, which has the largest caseload on the continent, has recorded nearly 2.93 million infections, with 687 new cases reported on Sunday, up from around 106 earlier this month.
  • Pfizer has meantime applied to the country’s regulatory bodies for clearance of its third dose "booster" shot.

Johannesburg


Covid-19 infections are on the rise in South Africa weeks ahead of an expected fourth wave in December, the country's national health laboratory service said Monday.

The National Institute for Communicable Diseases (NICD) reported a "sustained" increase over the past seven days, with the majority of cases detected in the most populous province of Gauteng, which includes Johannesburg and Pretoria.

"We are monitoring these trends to see if these increases persist," NICD's interim executive director, Adrian Puren, said in a statement.

Localised increases expected

He said that while localised increases were expected, "it is hard to say whether the increases indicate the start of a widespread resurgence".

South Africa, which has the largest caseload on the continent, has recorded nearly 2.93 million infections, with 687 new cases reported on Sunday, up from around 106 earlier this month.

Of the total cases, at least 89,574 have been fatal.

After a rather slow start, vaccination rates have picked up pace with 41 percent of adults in South Africa having received at least a single dose, while 35 percent are now fully vaccinated.

Pfizer has meantime applied to the country’s regulatory bodies for clearance of its third dose "booster" shot.

The South African Health Products Regulatory Authority said in a statement Monday that it received the application last Wednesday and will start "assessment of data for the safety and efficacy of the third dose"